MAPK3 and cancer: Among these kinase cascades, the Raf/MEK/ERK1/2 pathway is one of the most frequently dysregulated signaling pathways in cancer, particularly in solid tumors such as breast, melanoma, pancreatic, oral squamous cell, and colorectal cancers (reviewed in [43]).